Grant Parkins
Family Medicine · Spencer, WVNPI 1598769424
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 146 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $864 and has fallen 64.0% since, to $312 in 2025.
Across 146 payments — averaging $15.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$306
- Pfizer$289
- Johnson & Johnson$218
- Novo Nordisk$208
- AstraZeneca$200
- Lilly USA, LLC$143
- plus $913 from 22 others
What the payments were for
- Food & beverage$2,272100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 18 | $306 |
| Pfizer | 14 | $289 |
| Johnson & Johnson | 17 | $218 |
| Novo Nordisk | 13 | $208 |
| AstraZeneca | 13 | $200 |
| Lilly USA, LLC | 16 | $143 |
| Merck | 8 | $102 |
| Amgen | 6 | $85 |
| Dexcom, Inc. | 4 | $79 |
| Abbott | 5 | $77 |
| Amarin Pharma, Inc. | 5 | $69 |
| GSK | 4 | $67 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $49 |
| E.r. Squibb & Sons, L.L.C. | 3 | $44 |
| Medtronic | 1 | $43 |
| Ultragenyx Pharmaceutical Inc. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $32 |
| Ironshore Pharmaceuticals Inc. | 2 | $31 |
| AbbVie | 1 | $27 |
| Averitas Pharma Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $19 |
| Verona Pharma, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Pulmonx Corporation | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Boehringer Ingelheim | 1 | $11 |
How this compares
$2,277 in reported general payments places this provider in the 80th percentile of 843 family medicine providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 195 | $223,803 |
| EliquisApixaban | 134 | $88,311 |
| JardianceEmpagliflozin | 77 | $77,300 |
| XareltoRivaroxaban | 33 | $52,150 |
| TrulicityDulaglutide | 37 | $37,844 |
| JanuviaSitagliptin Phosphate | 48 | $30,223 |
| RybelsusSemaglutide | 21 | $26,221 |
| LinzessLinaclotide | 16 | $16,443 |
| Spiriva HandihalerTiotropium Bromide | 12 | $15,946 |
| TradjentaLinagliptin | 36 | $13,967 |
| MounjaroTirzepatide | 15 | $13,621 |
| InvokanaCanagliflozin | 11 | $13,057 |
| RexultiBrexpiprazole | 17 | $12,382 |
| BrilintaTicagrelor | 21 | $11,294 |
| Novolog FlexpenInsulin Aspart | 22 | $10,562 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $208 | $250,024216 claims |
| Boehringer IngelheimJardiance, Tradjenta | $11 | $91,268113 claims |
| PfizerEliquis | $289 | $88,311134 claims |
| Johnson & JohnsonXarelto, Invokana | $218 | $65,20744 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $143 | $51,46652 claims |
| MerckJanuvia | $102 | $30,22348 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arexvy | $67 | $24,53953 claims |
| AbbVieLinzess, Synthroid | $27 | $19,98242 claims |
| AstraZenecaBrilinta, Symbicort | $200 | $18,20339 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $19 | $12,38217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 843 family medicine providers in West Virginia.
Other family medicine in Spencer
- Julie DetempleSouth Charleston$129K
- John CornellHuntington$68K
- Isha WoofterClarksburg$27K
- Dominick WoofterClarksburg$27K
- Ryan RunyonPrinceton$21K
- David HessBridgeport$20K
- Cherry LobatonMartinsburg$19K
- Melissa GamponiaCharleston$18K
- Stephen MascioFollansbee$17K
- Kenneth AdkinsSouth Charleston$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.